España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Emily Austin
Benzinga Staff Writer
Rodman & Renshaw Reiterates Market Outperform on Dell
Rodman & Renshaw Reiterates Market Outperform and PT of $5.50 on U.S. Energy
UPDATE: MLV Reiterates Buy on Novavax, Reduces PT to $9.50
UPDATE: Rodman & Renshaw Reiterates Market Outperform on Crimson Exploration, Reduces PT to $5.25
Rodman & Renshaw Reiterates Market Outperform and PT of $10 on SciClone Pharmaceuticals
UPDATE: Bank of America Reiterates Buy on DeVry, Reduces PT to $62
Citi Reiterates Buy and PT of $63 on Intuit
Citi Reiterates Buy and PT of $50 on Nordstrom
UPDATE: Citi Reiterates Hold on NVIDIA, Reduces PT to $18
UPDATE: Goldman Sachs Reiterates Buy on Nordstrom, Raises PT to $55
Sterne Agee Reiterates Buy on Red Robin Gourmet Burgers
Rodman & Renshaw Initiates Coverage on Harvest Natural Resources with Market Outperform and PT of $20
UPDATE: FBN Reiterates Sector Perform on Emulex, Reduces PT to $8
Life Tech Capital Reiterates Strong Buy and PT of $4.75 on Oculus Innovative Sciences
Wunderlich Securities Initiates Coverage on PLX Technology with Hold and PT of $3.50
Wunderlich Securities Initiates Coverage on NetLogic Microsystems with Buy and PT of $40
Wunderlich Securities Initiates Coverage of Cavium with Hold and PT of $30
Deutsche Bank Updates 8/12
Citi Reiterates Buy and PT of $200 on Pharmasset
UPDATE: Citi Upgrades Discovery Communications to Buy, Maintains PT at $46